143 related articles for article (PubMed ID: 15200447)
1. Risk of malignancy with long-term immunosuppression in renal transplant recipients.
Agraharkar ML; Cinclair RD; Kuo YF; Daller JA; Shahinian VB
Kidney Int; 2004 Jul; 66(1):383-9. PubMed ID: 15200447
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the incidence of de novo solid malignancies after heart transplantation to that in the general population.
Kellerman L; Neugut A; Burke B; Mancini D
Am J Cardiol; 2009 Feb; 103(4):562-6. PubMed ID: 19195521
[TBL] [Abstract][Full Text] [Related]
3. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens.
Dantal J; Hourmant M; Cantarovich D; Giral M; Blancho G; Dreno B; Soulillou JP
Lancet; 1998 Feb; 351(9103):623-8. PubMed ID: 9500317
[TBL] [Abstract][Full Text] [Related]
4. De Novo Visceral Malignancies in Renal Transplant Recipients: A Single Center Experience of 2054 Recipients for More Than 30 Years.
Zavos G; Moris D; Kostakis ID; Vernadakis S; Bokos J; Zavvos V; Lionaki S; Boletis J
Exp Clin Transplant; 2015 Aug; 13(4):313-8. PubMed ID: 26295181
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppression in live-related donor renal transplantation.
Iman A; Rao M; Juneja R; Jacob CK
Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322
[TBL] [Abstract][Full Text] [Related]
6. Malignancy risk in patients with inflammatory eye disease treated with systemic immunosuppressive therapy: a tertiary referral cohort study.
Yates WB; Vajdic CM; Na R; McCluskey PJ; Wakefield D
Ophthalmology; 2015 Feb; 122(2):265-73. PubMed ID: 25312044
[TBL] [Abstract][Full Text] [Related]
7. Solid tumors following kidney transplantation in children.
Smith JM; Martz K; McDonald RA; Harmon WE
Pediatr Transplant; 2013 Dec; 17(8):726-30. PubMed ID: 24164825
[TBL] [Abstract][Full Text] [Related]
8. Malignancies after renal transplantation in Taiwan: a nationwide population-based study.
Li WH; Chen YJ; Tseng WC; Lin MW; Chen TJ; Chu SY; Hwang CY; Chen CC; Lee DD; Chang YT; Wang WJ; Liu HN
Nephrol Dial Transplant; 2012 Feb; 27(2):833-9. PubMed ID: 21633099
[TBL] [Abstract][Full Text] [Related]
9. A multi-institutional study of malignancies after heart transplantation and a comparison with the general United States population.
Higgins RS; Brown RN; Chang PP; Starling RC; Ewald GA; Tallaj JA; Kirklin JK; George JF
J Heart Lung Transplant; 2014 May; 33(5):478-85. PubMed ID: 24630406
[TBL] [Abstract][Full Text] [Related]
10. Treatment of oropharyngeal cancer in renal transplant recipients without cessation of immunosuppressive therapy.
Singh SK; Gupta AK; Jha V; Kohli HS; Gupta KL; Minz M; Sakhuja V
Transplant Proc; 2006 Sep; 38(7):2088-9. PubMed ID: 16980008
[TBL] [Abstract][Full Text] [Related]
11. De novo malignancies in renal transplant recipients: experience at a single center with 1882 transplant patients over 39 yr.
Apel H; Walschburger-Zorn K; Häberle L; Wach S; Engehausen DG; Wullich B
Clin Transplant; 2013; 27(1):E30-6. PubMed ID: 23278453
[TBL] [Abstract][Full Text] [Related]
12. Pancreas transplant outcomes for United States (US) cases reported to the United Network for Organ Sharing (UNOS) and non-US cases reported to the International Pancreas Transplant Registry (IPTR) as of October, 2000.
Gruessner AC; Sutherland DE
Clin Transpl; 2000; ():45-72. PubMed ID: 11512358
[TBL] [Abstract][Full Text] [Related]
13. Chronologically different incidences of post-transplant malignancies in renal transplant recipients: single center experience.
Ju MK; Joo DJ; Kim SJ; Huh KH; Kim MS; Jeon KO; Kim HJ; Kim SI; Kim YS
Transpl Int; 2009 Jun; 22(6):644-53. PubMed ID: 19220824
[TBL] [Abstract][Full Text] [Related]
14. The janus face of immunosuppression - de novo malignancy after renal transplantation: the experience of the Transplantation Center Munich.
Wimmer CD; Rentsch M; Crispin A; Illner WD; Arbogast H; Graeb C; Jauch KW; Guba M
Kidney Int; 2007 Jun; 71(12):1271-8. PubMed ID: 17332737
[TBL] [Abstract][Full Text] [Related]
15. Effect of immunosuppression for primary renal disease on the risk of cancer in subsequent renal transplantation: a population-based retrospective cohort study.
Hibberd AD; Trevillian PR; Wlodarczyk JH; Kemp DG; Stein AM; Gillies AH; Heer MK; Sheil AG
Transplantation; 2013 Jan; 95(1):122-7. PubMed ID: 23238532
[TBL] [Abstract][Full Text] [Related]
16. Malignancy in renal transplant recipients: a single-center experience in Thailand.
Ruangkanchanasetr P; Lauhawatana B; Leawseng S; Kitpanich S; Lumpaopong A; Thirakhupt P
J Med Assoc Thai; 2012 May; 95 Suppl 5():S12-6. PubMed ID: 22934439
[TBL] [Abstract][Full Text] [Related]
17. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center.
Mihalov ML; Gattuso P; Abraham K; Holmes EW; Reddy V
Clin Transplant; 1996 Jun; 10(3):248-55. PubMed ID: 8826661
[TBL] [Abstract][Full Text] [Related]
18. [Metabolic disorders in renal transplant recipients].
Mikolasević I; Jelić I; Sladoje-Martinović B; Orlić L; Zivcić-Cosić S; Vuksanović-Mikulicić S; Mijić M; Racki S
Acta Med Croatica; 2012 Jul; 66(3):235-41. PubMed ID: 23441539
[TBL] [Abstract][Full Text] [Related]
19. Conversion to everolimus in kidney transplant recipients: to believe or not believe?
Cotovio P; Neves M; Santos L; Macário F; Alves R; Mota A
Transplant Proc; 2012 Dec; 44(10):2966-70. PubMed ID: 23195007
[TBL] [Abstract][Full Text] [Related]
20. Malignancy following renal transplantation.
Yang TC; Shu KH; Cheng CH; Wu MJ; Lian JD
Zhonghua Yi Xue Za Zhi (Taipei); 1998 May; 61(5):281-8. PubMed ID: 9650432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
